Clinical Trials · NCT06546384
GLP-1 RA on Alcohol Consumption, Metabolism and Liver Parameters in Patients With Obesity and Fatty Liver Disease
- Phase
- N/A
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Insel Gruppe AG, University Hospital Bern
- Enrollment
- 64
- Start date
- May 2026
- Locations
- 1 site, Switzerland
- Primary endpoint
- Proportion of patients achieving total alcohol abstinence (measured by negative PEth test)